For the month ended 31 March 2026, Acme International Holdings Limited reported no changes in either authorised or issued share capital, underlining a stable equity structure throughout the period.

Authorised Share Capital • Remained at 4.00 billion ordinary shares with a par value of HKD 0.01, equivalent to HKD 40.00 million. • No increase or decrease was recorded during the month.

Issued Shares and Treasury Shares • Issued shares stayed at 1.02 billion ordinary shares. • The company held zero treasury shares, and there were no issuances, cancellations, or repurchases. • Consequently, the total number of issued shares closed the month unchanged at 1.02 billion.

Public Float Compliance • The company confirmed compliance with the Main Board’s 25% minimum public-float requirement as at 31 March 2026.

Equity Incentive Schemes • No share options were outstanding or exercised under either the Pre-IPO scheme (approved 21 March 2019) or the Share Option Scheme (approved 18 October 2019). • The 2019 scheme retains a capacity for up to 52.00 million shares to be granted in the future.

Other Equity Instruments • No warrants, convertible securities, or other agreements to issue shares were outstanding or executed during the month. • There were no other movements in treasury shares.

Regulatory Confirmation • Company Secretary Yu Chim Shun affirmed that all statutory and regulatory obligations related to equity and treasury share matters were satisfied for the reporting period.

The unchanged capital metrics suggest Acme International maintained its share base without dilution or buybacks during March 2026.